Ocular Therapeutix stock price target raised to $30 by RBC on wAMD trial outlook

Dec 9, 2025 - 10:00

0

Ocular Therapeutix stock price target raised to $30 by RBC on wAMD trial outlook

Related Posts

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 0

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025 3

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025 1

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025 1

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025 0

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025 1